Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Medecine Sciences : M/S
|
January 7, 2020
[Anti-tumor monoclonal antibodies: new insights to elicit a long-term immune response]
Claire Deligne, Laurent Gros
Frontiers in Oncology
|
March 15, 2021
Macrophages and Extracellular Matrix in Breast Cancer: Partners in Crime or Protective Allies?
Claire Deligne, Kim S Midwood
Medecine Sciences : M/S
|
January 29, 2013
[The Janus face of monoclonal antibodies in oncology: passive immunity and vaccination]
Claire Deligne, Jean-Luc Teillaud
Journal of Personalized Medicine
|
April 23, 2022
Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?
Claire Deligne, Sylvaine You, Roberto Mallone
Frontiers in Immunology
|
September 1, 2017
Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?
Claire Deligne, Benoît Milcent, Nathalie Josseaume, et al.
Frontiers in Immunology
|
August 27, 2021
Oral Fc-Coupled Preproinsulin Achieves Systemic and Thymic Delivery Through the Neonatal Fc Receptor and Partially Delays Autoimmune Diabetes
Noémie Corcos, Slobodan Culina, Claire Deligne, et al.
Methods in Cell Biology
|
January 10, 2018
How to detect and purify tenascin-C
Sean P Giblin, Devadarssen Murdamoothoo, Claire Deligne, et al.
European Journal of Immunology
|
December 20, 2024
Half-Life Extension of the IgG-Degrading Enzyme (IdeS) Using Fc-Fusion Technology
Victoria Daventure, Melissa Bou-Jaoudeh, Emna Hannachi, et al.
European Journal of Immunology
|
July 2, 2026
Fast Generation of F(Ab')<sub>2</sub> Fragments From Human IgG Using Fc-Fused IgG-Degrading Enzyme
Emna Hannachi, Robin V Lacombe, Amélia Trecco, et al.
Haematologica
|
January 19, 2023
The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A mice
Melissa Bou-Jaoudeh, Sandrine Delignat, Victoria Daventure, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Medecine Sciences : M/S
|
January 7, 2020
[Anti-tumor monoclonal antibodies: new insights to elicit a long-term immune response]
Claire Deligne, Laurent Gros
Frontiers in Oncology
|
March 15, 2021
Macrophages and Extracellular Matrix in Breast Cancer: Partners in Crime or Protective Allies?
Claire Deligne, Kim S Midwood
Medecine Sciences : M/S
|
January 29, 2013
[The Janus face of monoclonal antibodies in oncology: passive immunity and vaccination]
Claire Deligne, Jean-Luc Teillaud
Journal of Personalized Medicine
|
April 23, 2022
Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?
Claire Deligne, Sylvaine You, Roberto Mallone
Frontiers in Immunology
|
September 1, 2017
Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?
Claire Deligne, Benoît Milcent, Nathalie Josseaume, et al.
Frontiers in Immunology
|
August 27, 2021
Oral Fc-Coupled Preproinsulin Achieves Systemic and Thymic Delivery Through the Neonatal Fc Receptor and Partially Delays Autoimmune Diabetes
Noémie Corcos, Slobodan Culina, Claire Deligne, et al.
Methods in Cell Biology
|
January 10, 2018
How to detect and purify tenascin-C
Sean P Giblin, Devadarssen Murdamoothoo, Claire Deligne, et al.
European Journal of Immunology
|
December 20, 2024
Half-Life Extension of the IgG-Degrading Enzyme (IdeS) Using Fc-Fusion Technology
Victoria Daventure, Melissa Bou-Jaoudeh, Emna Hannachi, et al.
European Journal of Immunology
|
July 2, 2026
Fast Generation of F(Ab')<sub>2</sub> Fragments From Human IgG Using Fc-Fused IgG-Degrading Enzyme
Emna Hannachi, Robin V Lacombe, Amélia Trecco, et al.
Haematologica
|
January 19, 2023
The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A mice
Melissa Bou-Jaoudeh, Sandrine Delignat, Victoria Daventure, et al.
Page
of 2